Real examples of how IronPost Media creates compliant content for medical device companies across LinkedIn, X, and Instagram. Every post includes fair balance, avoids off-label claims, and is audit-ready.
Each post below is tagged with its compliance attributes. FDA Compliant means the post meets fair balance and labeling requirements. Fair Balance means risk/benefit information is appropriately included. Educational means the content is informational and avoids promotional claims. These are the standards every IronPost Media post meets before publishing.
New study published in the Journal of Respiratory Medicine examines outcomes in patients using high-flow nasal cannula therapy during post-operative recovery. Results suggest improved oxygenation metrics in the study population (n=240).
Important: Individual outcomes may vary. High-flow therapy is indicated for patients requiring supplemental oxygen. Contraindications include nasal obstruction and certain facial trauma. Full prescribing information available via the link in our bio.
Respiratory therapists: new peer-reviewed data on high-flow nasal cannula in post-op recovery is now available in the Journal of Respiratory Medicine.
Outcomes vary by patient. Review full safety and prescribing info before use. Link in bio.
[Infographic] Understanding high-flow nasal cannula: how it works, approved indications, and what clinicians need to know.
This device is FDA-cleared for supplemental oxygen delivery. Not all patients are candidates. See full indications, contraindications, and safety info at the link in bio. Always consult prescribing information before use.
Operational spotlight: How one mid-size ENT device company reduced time-to-market by 4 months through streamlined regulatory submissions and cross-functional alignment.
No two regulatory paths are identical. Results reflect a specific company's experience and may not be representative of all organizations. Regulatory timelines depend on device classification, submission quality, and FDA workload.
FDA reminder: social media posts about medical devices are subject to the same fair balance requirements as print ads.
If you mention benefits, you must include risks. If you link to a claim, you must link to the full prescribing information. No exceptions.
[Carousel] 5 common FDA compliance mistakes in medtech social media:
1. Sharing patient testimonials without fair balance
2. Making efficacy claims beyond approved labeling
3. Using hashtags that imply off-label use
4. Reposting HCP content without regulatory review
5. Missing ISI (Important Safety Information) links
Each slide includes the regulatory reference and how to fix it. Educational content only.
Tracheostomy care awareness: Approximately 100,000 tracheostomies are performed annually in the U.S. Proper cannula selection and maintenance are critical to patient outcomes.
Device selection should be based on clinical assessment by qualified healthcare providers. All tracheostomy devices carry risks including obstruction, displacement, and infection. See device-specific labeling for complete safety information.
Attending the MedTech Conference next month? IronPost Media will be discussing compliant social media strategies for device companies at booth #247.
Stop by to discuss how your team can build a social presence without regulatory risk. No product demos -- just strategy conversations.
[Behind the scenes] What our compliance review process looks like before any medtech post goes live:
1. Draft content reviewed against approved labeling
2. Fair balance language verified
3. Off-label claim screening
4. ISI link verification
5. Archive snapshot saved for audit trail
Every post. Every time. No shortcuts on compliance.
Every content calendar is custom-built around your approved indications, regulatory history, and target audience.
Request a Proposal →